Market Research Report Store (MRRS) adds “Trigeminal Neuralgia – Pipeline Review, H1 2017” latest studies, published in March 2017. It is a professional and in-depth study.
Summary
Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Trigeminal Neuralgia – Pipeline Review, H1 2017, provides an overview of the Trigeminal Neuralgia (Central Nervous System) pipeline landscape.
Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. Symptoms include spontaneous attacks of pain or attacks triggered by things such as touching the face, chewing, speaking and brushing teeth, pain in areas supplied by the trigeminal nerve, including the cheek, jaw, teeth, gums, lips, or less often the eye and forehead.
Report Highlights
Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Trigeminal Neuralgia – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Trigeminal Neuralgia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Trigeminal Neuralgia (Central Nervous System).
– The pipeline guide reviews pipeline therapeutics for Trigeminal Neuralgia (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Trigeminal Neuralgia (Central Nervous System) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Trigeminal Neuralgia (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Trigeminal Neuralgia (Central Nervous System)
Get PDF Sample of Report at
https://www.marketresearchreportstore.com/shop/trigeminal-neuralgia-pipeline-review-h1-2017
Or For more information, please feel free to contact us:
Helen | Sales Director
Call: +00-1-626-3463946 – U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/